Duopharma Biotech Granted Conditional Registration Approval for COVID 19 Sinopharm Vaccine
KUALA LUMPUR, 16 July 2021 – Duopharma (M) Sendirian Berhad, a wholly-owned
subsidiary of Duopharma Biotech Berhad (“Duopharma Biotech”), has been granted
conditional registration approval by Malaysia’s Drug Control Authority (“DCA”) for the Covid-
19 Sinopharm vaccine developed by China National Biotec Group Company Limited
(“Sinopharm CNBG”).